Similar Papers

Paper Title
Journal
Date
Author
P1020: SCREENING FOR PORTAL HYPERTENSION IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
M Davidson ... J Callum
HemaSphere | VOL. 6
M Davidson, et. al.M Davidson ... J Callum
23 Jun 2022
Portal vein thrombosis in adults: pathophysiology, pathogenesis and management
Dominique-Charles Valla ... Bertrand Condat
Journal of Hepatology | VOL. 32
Dominique-Charles Valla, et. al.Dominique-Charles Valla ... Bertrand Condat
01 May 2000
Safety and Efficacy of JAK Inhibitor Therapy in BCR-ABL Negative MPN Patients with Underlying Portal Hypertension
Marta Davidson ... Taylor Nye
Blood | VOL. 138
Marta Davidson, et. al.Marta Davidson ... Taylor Nye
05 Nov 2021
Gender Is a Core Modifier of Disease Outcomes and Survival in the MPN
Brady Stein ... Alison R Moliterno
Blood | VOL. 126
Brady Stein, et. al.Brady Stein ... Alison R Moliterno
03 Dec 2015
View more papers

More From: American journal of hematology

Paper Title
Journal
Date
Author
Association Between Anticoagulant-Related Bleeding and Mortality in Patients With Solid Tumors and Cancer-Associated Venous Thromboembolism.
Amir Mahmoud ... Kristen M Sanfilippo
American journal of hematology | VOL. -
Amir Mahmoud, et. al.Amir Mahmoud ... Kristen M Sanfilippo
21 Jan 2025
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents.
Giovanni Marconi ... Giovanni Martinelli
American journal of hematology | VOL. -
Giovanni Marconi, et. al.Giovanni Marconi ... Giovanni Martinelli
20 Jan 2025
Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers.
Emma N Cravo ... Gary A Smith
American journal of hematology | VOL. -
Emma N Cravo, et. al.Emma N Cravo ... Gary A Smith
17 Jan 2025
Clinical Validation of Optical Genome Mapping in Multiple Myeloma Without Plasma Cell Enrichment.
Jung Yoon ... Soo-Young Yoon
American journal of hematology | VOL. -
Jung Yoon, et. al.Jung Yoon ... Soo-Young Yoon
17 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.